300639 凯普生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-0.2972.87642.60930.51620.889
总资产报酬率 ROA (%)-0.2552.25431.46024.04417.461
投入资产回报率 ROIC (%)-0.2892.76440.12528.79320.296

边际利润分析
销售毛利率 (%)50.30661.02969.36467.63373.366
营业利润率 (%)-17.2473.85739.18540.17134.614
息税前利润/营业总收入 (%)-16.8372.29137.96839.69334.048
净利润/营业总收入 (%)-15.1806.20332.19333.10629.137

收益指标分析
经营活动净收益/利润总额(%)135.94417.449130.114103.498101.699
价值变动净收益/利润总额(%)-4.04037.8701.0031.9491.148
营业外收支净额/利润总额(%)5.720-15.710-3.069-1.570-1.048

偿债能力分析
流动比率 (X)8.1116.2553.2293.7676.475
速动比率 (X)7.8476.0593.1423.5506.157
资产负债率 (%)8.75910.95122.45417.8750.113
带息债务/全部投入资本 (%)0.6680.7292.2614.5183.253
股东权益/带息债务 (%)14,591.58513,367.9604,194.7152,062.4722,949.580
股东权益/负债合计 (%)995.365775.256324.196422.329740.824
利息保障倍数 (X)-11.564-2.198-755.637278.471-165.019

营运能力分析
应收账款周转天数 (天)914.007751.262123.204113.309120.417
存货周转天数 (天)97.12991.29127.91150.64969.714